Chronic pulmonary aspergillosis as a sequel to lobectomy for lung cancer

Interactive Cardiovascular and Thoracic Surgery
Atsuhisa TamuraFumiaki Takahashi

Abstract

Chronic pulmonary aspergillosis (CPA) is an emerging complication after lobectomy for lung cancer. This retrospective study aimed to determine the incidence, main risk factors and clinical features of postoperative CPA in lung cancer patients. This study included lung cancer patients treated by lobectomy and with no previous history of thoracic surgery or coexistent aspergillosis at the time of surgery. The cumulative incidence of CPA was determined using death as a competing risk. Furthermore, the identified lung cancer patients were divided into CPA and non-CPA groups to compare their preoperative clinical features and to identify the risk factors of postoperative CPA by univariable and multivariable analyses. We also analysed the clinical features of CPA patients after diagnosis. We included 475 lung cancer patients. Of these, 17 patients (3.6%) developed CPA after the lobectomy. The cumulative postoperative incidence rate of CPA was 2.3% [95% confidence interval (CI), 0.8-3.8%] at 5 years and 7.9% (95% CI, 3.0-13.0%) at 10 years. There were significantly more men (P = 0.007), smokers (P = 0.002) and comorbid chronic obstructive pulmonary disease (COPD) (P = 0.008) and interstitial lung disease (ILD) (P = 0.009) patients in ...Continue Reading

References

Jan 1, 1993·Scandinavian Journal of Thoracic and Cardiovascular Surgery·T HanagiriT Shirakusa
Dec 24, 1997·The Thoracic and Cardiovascular Surgeon·H UedaT Iwanaga
Jun 12, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yasuo SekineTakehiko Fujisawa
Sep 17, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David W DenningHelen Sambatakou
Oct 12, 2007·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Hisaichi TanakaKeiji Iuchi
Jan 29, 2008·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Mark K Ferguson, Wickii T Vigneswaran
Jul 10, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G D'AddarioUNKNOWN ESMO Guidelines Working Group
Sep 16, 2009·Journal de radiologie·B PadovaniJ Mouroux
Nov 17, 2009·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Hae-Seong NamWon-Jung Koh
Jul 3, 2010·The European Respiratory Journal·N L Smith, D W Denning
Mar 24, 2011·AJR. American Journal of Roentgenology·Hiroaki Arakawa, Koichi Honma
Jan 25, 2012·Bulletin of the World Health Organization·David W DenningDonald C Cole
Feb 22, 2012·Respiratory Medicine·Hisano OhbaKingo Chida
Jun 26, 2013·Journal of Postgraduate Medicine·N KumarV Tripathi
Jul 26, 2013·Japanese Journal of Infectious Diseases·Takayoshi TashiroShigeru Kohno
Dec 19, 2013·Mediators of Inflammation·Naobumi TochigiKazutoshi Shibuya
Jun 20, 2014·Respiration; International Review of Thoracic Diseases·Cendrine GodetJacques Cadranel

❮ Previous
Next ❯

Citations

Oct 21, 2015·Interactive Cardiovascular and Thoracic Surgery·Tomislav Mestrovic
Jun 7, 2016·Journal of Fungi·Gemma E Hayes, Lilyann Novak-Frazer
Jan 23, 2021·The European Respiratory Journal·Thomas MaitreJacques Cadranel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.